Quick Takeaways
- AQR CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for HAEMONETICS CORP Common stock, $.01 par value per share (HAE).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2025.
AQR CAPITAL MANAGEMENT LLC - 31 Dec 2025 SCHEDULE 13G Report for HAEMONETICS CORP Common stock, $.01 par value per share (HAE)
- Filing Manager
- AQR CAPITAL MANAGEMENT LLC
- Reporting Manager
- AQR Capital Management, LLC
- Symbol
- HAE
- Shares outstanding
- 46,791,479 shares
- Disclosed Ownership
- 3,163,104 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2026, 10:10:32 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AQR CAPITAL MANAGEMENT LLC disclosed 6.8% ownership in HAEMONETICS CORP Common stock, $.01 par value per share (HAE) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2026, 10:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AQR Capital Management, LLC | 6.8% | 3,163,104 | 0 | 3,163,104 | Henry Parkin | Authorized Signatory | |
| AQR Capital Management Holdings, LLC | 6.8% | 3,163,104 | 0 | 3,163,104 | Henry Parkin | Authorized Signatory |